Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01688973
What this trial is testing

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Active Not RecruitingNCT04235777
What this trial is testing

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

Who this might be right for
Urothelial CancerBladder CancerGenitourinary Cancer+2 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT03379012
What this trial is testing

Testosterone in Metastatic Renal Cell Carcinoma Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Kidney Cancer Research Bureau 60
Testing effectiveness (Phase 2)Looking for participantsNCT06730672
What this trial is testing

An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus

Who this might be right for
Renal Cell Carcinoma Stage I
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Ended earlyNCT01453595
What this trial is testing

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cancer
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Active Not RecruitingNCT05653882
What this trial is testing

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerMelanoma+2 more
Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT00848640
What this trial is testing

Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Egyptian Foundation For Cancer Research 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Early research (Phase 1)Study completedNCT02264548
What this trial is testing

A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy

Who this might be right for
Renal Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 14
Not applicableStudy completedNCT06339138
What this trial is testing

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Papillary Renal TumorClear Cell Renal Cell Carcinoma+3 more
Mayo Clinic 589
Testing effectiveness (Phase 2)Looking for participantsNCT06222593
What this trial is testing

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

Who this might be right for
Carcinoma, Renal Cell
State University of New York at Buffalo 28
Not applicableActive Not RecruitingNCT07060248
What this trial is testing

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

Who this might be right for
Renal Cell Carcinoma (RCC)
Second Xiangya Hospital of Central South University 700
Not applicableStudy completedNCT01728948
What this trial is testing

Sorafenib in Elderly mRCC

Who this might be right for
Carcinoma, Renal Cell
Bayer 60
Testing effectiveness (Phase 2)Looking for participantsNCT06750185
What this trial is testing

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 248
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022343
What this trial is testing

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8
Emory University 22
Early research (Phase 1)Study completedNCT00625768
What this trial is testing

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Malignant Melanoma
Antisoma Research 13
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Not applicableWithdrawnNCT04555603
What this trial is testing

Axitinib Therapy Management Study

Who this might be right for
Renal Cell Carcinoma
Pfizer
Next Page